Pulmonary Disease Doctors in Kirkland, WA Accepting Medicare

4 Pulmonary Disease doctors found. Showing 1 - 4

Dr. Supriya Kelkar Mystkowski, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 11521 Ne 128th St Ste 130, Kirkland, WA 98034 Phone: 425-899-4280    Fax: 425-899-4294

Dr. Sukriti Singhal, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 218 Main St, Pmb 486, Kirkland, WA 98033 Phone: 201-615-7091

Michael D Eulberg, Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 12911 120th Ave Ne, Suite G105, Kirkland, WA 98034 Phone: 425-899-6972    Fax: 425-899-6970

Bridget Collins, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 12303 Ne 130th Ln Ste Coral550, Kirkland, WA 98034 Phone: 425-899-6972    Fax: 425-899-6970

News Archive

Optimer Pharmaceuticals receives production patent for Fidaxomicin

Optimer Pharmaceuticals, Inc. has announced that the United States Patent and Trademark Office issued a production patent (U.S. Patent No. 7,507,564) covering steps used in the manufacture of fidaxomicin, which is currently in its second Phase 3 clinical trial for the treatment of Clostridium difficile infection, or CDI.

BioSpecifics Technologies total revenues for first-quarter increase to $2.7M

BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products, today announced its financial results for the first quarter ended March 31, 2010. The Company also highlighted key commercial and regulatory progress during the quarter, and provided its expected milestones for the remainder of 2010.

Pfizer's first-quarter 2010 revenues increase 54% to $16.8 billion

Pfizer Inc. today reported financial results for first-quarter 2010. Since the acquisition of Wyeth was completed on October 15, 2009, legacy Wyeth operations are reflected in first-quarter 2010 results, but not in first-quarter 2009 results. First-quarter 2010 revenues were $16.8 billion, an increase of 54% compared with $10.9 billion in the year-ago quarter.

Dutaseride may help prevent progression of early stage prostate cancer: Study

A new study suggests that men with early stage prostate cancer may benefit with drugs that can slow or stop the cancer's progress. Less than 10 percent of the 100,000 men each year who are diagnosed with early-stage prostate cancer and have the option of leaving the cancer in place. Rest get it removed using surgery or radiation. But those treatments can have serious side effects like impotence and incontinence.

Patients with poorly controlled diabetes may benefit from behavioral, educational interventions

Three randomized controlled trials published Online First today in Archives of Internal Medicine examine the effectiveness of behavioral and educational interventions for patients with poorly controlled diabetes.

Read more Medical News

› Verified 7 days ago